Literature DB >> 16546284

Intein-mediated protein purification of fusion proteins expressed under high-cell density conditions in E. coli.

Shamik S Sharma1, Shaorong Chong, Sarah W Harcum.   

Abstract

The intein-mediated purification system has the potential to significantly reduce the recovery costs of industrial recombinant proteins. The ability of inteins to catalyze a controllable peptide bond cleavage reaction can be used to separate a recombinant protein from its affinity tag during affinity purification. Inteins have been combined with a chitin-binding domain to serve as a self-cleaving affinity tag, facilitating highly selective capture of the fusion protein on an inexpensive substrate--chitin (IMPACT) system, New England Biolabs, Beverly, MA). This purification system has been used successfully at a lab scale in low cell density cultures, but has not been examined comprehensively under high-cell density conditions in defined medium. In this study, the intein-mediated purification of three commercially relevant proteins expressed under high-cell density conditions in E. coli was studied. Additionally, losses during the purification process were quantified. The data indicate that the intein fusion proteins expressed under high cell density fermentations were stable in vivo after induction for a significant duration, and the intein fusion proteins could undergo thiol or pH and temperature initiated cleavage reaction in vitro. Thus, the intein-mediated protein purification system potentially could be employed for the production of recombinant proteins at the industrial-scale.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546284     DOI: 10.1016/j.jbiotec.2006.01.018

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  8 in total

1.  Recombinant chymosin used for exact and complete removal of a prochymosin derived fusion tag releasing intact native target protein.

Authors:  Sune F L Justesen; Kasper Lamberth; Lise-Lotte B Nielsen; Claus Schafer-Nielsen; Søren Buus
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

2.  Electronic structure of neighboring extein residue modulates intein C-terminal cleavage activity.

Authors:  Philip T Shemella; Natalya I Topilina; Ikko Soga; Brian Pereira; Georges Belfort; Marlene Belfort; Saroj K Nayak
Journal:  Biophys J       Date:  2011-05-04       Impact factor: 4.033

3.  Crystal structure of the Vibrio cholerae colonization factor TcpF and identification of a functional immunogenic site.

Authors:  Christina J Megli; Alex S W Yuen; Subramaniapillai Kolappan; Malcolm R Richardson; Madushini N Dharmasena; Shelly J Krebs; Ronald K Taylor; Lisa Craig
Journal:  J Mol Biol       Date:  2011-04-01       Impact factor: 5.469

4.  Microbial polyhydroxyalkanote synthesis repression protein PhaR as an affinity tag for recombinant protein purification.

Authors:  Shuang Zhang; Zhi Hui Wang; Guo Qiang Chen
Journal:  Microb Cell Fact       Date:  2010-05-10       Impact factor: 5.328

Review 5.  Inteins, valuable genetic elements in molecular biology and biotechnology.

Authors:  Skander Elleuche; Stefanie Pöggeler
Journal:  Appl Microbiol Biotechnol       Date:  2010-05-07       Impact factor: 4.813

6.  Production of Nα-acetylated thymosin α1 in Escherichia coli.

Authors:  Yuantao Ren; Xueqin Yao; Hongmei Dai; Shulong Li; Hongqing Fang; Huipeng Chen; Changlin Zhou
Journal:  Microb Cell Fact       Date:  2011-04-22       Impact factor: 5.328

7.  Gold Nanoparticles Augment N-Terminal Cleavage and Splicing Reactions in Mycobacterium tuberculosis SufB.

Authors:  Ananya Nanda; Sourya Subhra Nasker; Anoop K Kushwaha; Deepak Kumar Ojha; Albert K Dearden; Saroj K Nayak; Sasmita Nayak
Journal:  Front Bioeng Biotechnol       Date:  2021-12-23

8.  Optimization and One-Step Purification of Recombinant V Antigen Production from Yersinia pestis.

Authors:  Elahe Seyed Hosseini; Mehdi Zeinoddini; Ali Reza Saeedinia; Valiollah Babaeipour
Journal:  Mol Biotechnol       Date:  2020-03       Impact factor: 2.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.